logo
Select company
Select metric
$ -145.39MEarning Before Interest & Taxes (EBIT)
VS
Market
7
Sector
14
Industry
19
History
-
$ 9.03Close
$ 1.1 - $ 9.52 52-Week Range
Ticker Information

Ticker

TNGX

Company Name

TANGO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TANGO THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TNGX - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -145.39M
3/31/2025$ -132.06M
12/31/2024$ -130.09M
9/30/2024$ -123.19M
6/30/2024$ -116.32M
3/31/2024$ -111.48M
12/31/2023$ -101.61M
9/30/2023$ -99.9M
6/30/2023$ -106.71M
3/31/2023$ -110.92M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TANGO THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -116.18K.
  • Over the past 5 years, TANGO THERAPEUTICS INC's average EBIT has been $ -98.54M.
  • The median EBIT for TANGO THERAPEUTICS INC during this period was $ -106.71M
  • TANGO THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ -116.18K.
  • The lowest EBIT recorded by TANGO THERAPEUTICS INC in the same timeframe $ -145.39M

TANGO THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
VIR : VIR BIOTECHNOLOGY INC $ -549.95MQURE : UNIQURE NV $ -135.06MNUVB : NUVATION BIO INC $ -202.21MAUTL : AUTOLUS THERAPEUTICS PLC $ -240.51MABUS : ARBUTUS BIOPHARMA CORP $ -54.14MZBIO : ZENAS BIOPHARMA INC $ -176.76MBCYC : BICYCLE THERAPEUTICS PLC $ -248.02MALMS : ALUMIS INC $ -236.08MFHTX : FOGHORN THERAPEUTICS INC $ -75.39MIMNM : IMMUNOME INC $ -212.39M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

TNGX - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -145.39M

Minimum

Jun 30, 2025

$ -116.18K

Maximum

Dec 31, 2020

$ -98.54M

Average

$ -106.71M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M